The limulus gelation assay was utilized to investigate endotoxin inactivation by a number of antibiotics in vitro. Endotoxin activity was sharply reduced by polymyxin B and sodium colistimethate. The effect of the polymyxin was not significantly inhibited by 0.001 M calcium or 90% serum. Crude endotoxins from a variety of aerobic gram-negative bacteria, including several not previously studied, could be inactivated 1 or more logs by as little as 1 Og of polymyxin B per ml, whereas Bacteroides fragilis endotoxin was poorly detoxified. A 10,000-fold range in the relative susceptibility of different endotoxins to inactivation by polymyxin B was found. The endotoxin most susceptible to polymyxin B was derived from an organism resistant to polymyxin B by disk sensitivity testing, suggesting that the bacteriocidal and endotoxin detoxifying properties of polymyxin need not be directly related.
The limulus gelation assay was utilized to investigate endotoxin inactivation by a number of antibiotics in vitro. Endotoxin activity was sharply reduced by polymyxin B and sodium colistimethate. The effect of the polymyxin was not significantly inhibited by 0.001 M calcium or 90% serum. Crude endotoxins from a variety of aerobic gram-negative bacteria, including several not previously studied, could be inactivated 1 or more logs by as little as 1 Og of polymyxin B per ml, whereas Bacteroides fragilis endotoxin was poorly detoxified. A 10,000-fold range in the relative susceptibility of different endotoxins to inactivation by polymyxin B was found. The endotoxin most susceptible to polymyxin B was derived from an organism resistant to polymyxin B by disk sensitivity testing, suggesting that the bacteriocidal and endotoxin detoxifying properties of polymyxin need not be directly related.
Recent studies have demonstrated the capacity of polymyxin B to protect animals from a variety of toxic effects of endotoxin, including the generalized Schwartzman reaction (5, 23) , diffuse intravascular coagulation (6, 7) , renal cortical necrosis (6, 7), leukopenia (6, 7) , and death (6, 12, 21, 23) . The limulus gelation test, developed by Levin and others (13, 14) , has provided a useful in vitro means to assess an endotoxin activity which corresponds with in vivo indices of toxicity (3, 15, 24) . We have previously found this assay to be useful in evaluating endotoxin inactivation processes (4). The present study was designed to evaluate the effect of polymyxin B and other antibiotics upon endotoxin, the conditions of the reaction, and the relative polymyxin susceptibility of endotoxins from a variety of gram-negative bacteria. (19) .
MATERIALS AND METHODS

RESULTS
E. coli 026:B6 endotoxin (5 ng/ml) was not demonstrably altered by chloramphenicol (1, 000 ,ug/ml), gentamicin (50 jsg/ml), streptomycin (100 lOg/ml), tetracycline (25 ,ug/ml), ampicillin (100 jg/ml), carbenicillin (100 Ag/ml), or sulfisoxazole (400 ,g/ml), although it was neutralized by polymyxin B (50 ,ug/ml). Polymyxin B (1 ,g/ ml) deactivated 100 ng of this endotoxin per ml by at least 2 log despite the presence of 0.001 M CaCl2; hydrolyzed sodium colistimethate also sharply inhibited endotoxin activity, although this effect may have been somewhat reduced in the presence of 0.001 M CaCl2 (Table 1) . Greater than 1-log inactivation could also be demonstrated in the presence of 90% normal human serum (Table 2) .
In further experiments, polymyxin B was observed to induce a marked decline in the activity of endotoxin preparations from five aerobic gram-negative organisms, whereas there was relatively minimal decline in the activity of polymyxin-treated Bacteroides fragilis endotoxin (Fig. 1) . Susceptibility of the various endotoxins to polymyxin B varied over a 10,000-fold range. The endotoxin most sensitive to polymyxin B was derived from a strain of Proteus mirabiis which had been demonstrated to be resistant to the antibacterial action of polymyxin B by routine disk-sensitivity testing. Previous investigations have shown in vivo protection by polymyxin against E. coli, Aerobacter aerogenes, and Serratia marcesans endotoxins (5-7, 12, 20-23); the current study extends these observations to include inactivation of Proteus, Klebsiella, and Neisseria endotoxins as well. However, a 10,000-fold variation in susceptibility of the various endotoxins was found. Rifkind (21) has clearly demonstrated some degree of interdependence between parent-bacterial susceptibility and susceptibility of the derived endotoxin to polymyxin B. Nonetheless, it is evident that these two properties may at times be sharply divergent, since Proteus mirabilis, an organism resistant to the bactericidal effect of polymyxin, produced an endotoxin which was highly sensitive (Fig. 1) .
Bactericidal activity of the polymyxins may be blocked by low concentrations of calcium or serum (9, 18) . However, endotoxin detoxification by polymyxin B was not inhibited by such treatment in the present study.
The finding that a variety of gram-negative bacterial endotoxins can be inactivated in vitro by polymyxin B, together with previous in vivo animal protection studies (5-7, 12, 20-23) , suggests that it might well be possible to decrease endotoxin activity in man with polymyxin B therapy. Serum levels of polymyxin well above 1 ,g/ml can be readily achieved (25) . Levels of endotoxin which can be inactivated by this means (Table 1) appear to be in excess of those observed in the plasma of adult (2) and pediatric patients (M. S. Cooperstock, unpublished data). However, the clinical role of endotoxindetoxifying agents can be defined only with clarification of the role of endotoxin in human disease. While circulating endotoxin-like materials have been demonstrated in clinical populations, the findings are divided as to whether endotoxemia can (8, 10, 15) or cannot (10, 16, 24) be correlated with clinical outcome. Since quantitative studies of human endotoxemia are few, toxic levels under various clinical conditions remain undefined. One such study found that levels of circulating endotoxin-linked antigens correlate well with mortality in meningococcemia (10) . This finding and the present demonstration that Neisseria meningiditis endotoxin is sensitive to polymyxin merit further evaluation in view of possible clinical usefulness if confirmed.
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